documents: FDA-2017-D-3101-0022
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-D-3101-0022 | FDA | FDA-2017-D-3101 | Abbreviated New Drug Applications: Pre-Submission Facility Correspondence Related to Prioritized Generic Drug Submissions; Guidance for Industry; Availability | Notice | Notice of Availability | 2025-06-16T04:00:00Z | 2025 | 6 | 2025-06-16T04:00:00Z | 2025-06-16T17:46:03Z | 2025-10922 | 0 | 0 | 09000064b8e12d9a |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref